Sound Shore Management Portfolio in 2026: Top Holdings & Recent Changes
Welcome to the Value Sense Blog, your resource for insights on the stock market! At Value Sense, we focus on intrinsic value tools and offer stock ideas with undervalued companies. Dive into our research products and learn more about our unique approach at valuesense.io
Explore diverse stock ideas covering technology, healthcare, and commodities sectors. Our insights are crafted to help investors spot opportunities in undervalued growth stocks, enhancing potential returns. Visit us to see evaluations and in-depth market research.
Sound Shore Management continues its disciplined value investing approach with dynamic adjustments in its latest 13F filing. The firm's $3.1B portfolio shows notable activity across healthcare, technology, and utilities, including new buys and significant additions amid a portfolio trim to 37 positions.
Portfolio Overview: Balanced Diversification with Tactical Precision
Portfolio Highlights (Q4’2025): - Market Value: $3,142.6M - Top 10 Holdings: 35.3% - Portfolio Size: 37 -1 - Average Holding Period: 8 quarters - Turnover: 18.9%
Sound Shore Management's Q4 2025 portfolio maintains a diversified structure with 37 positions, reflecting a prudent balance between conviction bets and broader exposure. The top 10 holdings represent just 35.3% of assets, indicating a strategy that avoids over-reliance on a few names while allowing for meaningful position sizes. With an average holding period of 8 quarters (about two years), the firm demonstrates patience in value realization, holding through market cycles until intrinsic worth emerges.
Turnover at 18.9% signals active management without excessive trading, as the firm trimmed one position overall. This level of activity—higher than passive indexing but disciplined—suggests ongoing reassessment of opportunities, particularly in beaten-down sectors. The portfolio's evolution points to a value-oriented framework that favors quality businesses at attractive valuations, blending long-term holds with opportunistic adjustments.
Top Holdings: Pharma Bets, Tech Adds, and Utility Momentum
The portfolio's changes highlight Sound Shore's focus on high-conviction moves, starting with a new position in Regeneron Pharmaceuticals (REGN) at 4.3% $135.8M, signaling fresh interest in biotech innovation. Alongside this, the firm significantly reduced Teva Pharmaceutical Industries (TEVA) by 26.28% to 4.3% $134.5M, potentially locking in gains or reallocating from generics exposure.
Technology remains a key theme, with an addition of 7.87% to Alphabet (GOOGL) at 3.5% $109.5M, underscoring confidence in digital advertising and AI growth. Utilities saw aggressive expansion via a 66.63% add to Public Service Enterprise Group (PEG) (3.5%, $109.4M) and 34.08% to The Walt Disney Company (DIS) (3.5%, $109.1M), betting on defensive stability amid volatility. Further conviction appears in a 17.28% increase to Berkshire Hathaway (BRK-B) (3.4%, $105.7M), a nod to timeless value compounding.
A minor trim of 0.67% in Southwest Airlines (LUV) holds it at 3.3% $104.2M, while tech semis gained a 3.61% boost in QUALCOMM (QCOM) (3.2%, $100.7M). New entry Salesforce (CRM) (Buy, 3.2%, $100.3M) and a 17.00% add to The AES Corporation (AES) (3.1%, $98.9M) round out the active top tier, blending growth and infrastructure plays.
Most investors waste time on the wrong metrics. We've spent 10,000+ hours perfecting our value investing engine to find what actually matters.
Want to see what we'll uncover next - before everyone else does?
Find Hidden Gems First!
What the Portfolio Reveals
Sound Shore Management's Q4 moves reveal a strategy emphasizing resilient sectors with undervalued growth potential:
- Healthcare pivot: New buy in REGN and trim in TEVA suggest selectivity for innovative pharma over commoditized generics.
- Tech and mega-cap conviction: Adds to GOOGL, QCOM, and CRM indicate bets on AI, cloud, and semiconductors amid market rotation.
- Defensive utilities surge: Massive increases in PEG and AES point to inflation hedges and stable cash flows.
- Quality compounding: Boost to BRK-B reinforces preference for proven managers over speculative bets.
- Risk management: 18.9% turnover and portfolio trim balance aggression with discipline, maintaining geographic focus on U.S. large-caps.
Portfolio Concentration Analysis
| Position | Value | % of Portfolio | Recent Change |
|---|---|---|---|
| Regeneron Pharmaceuticals, Inc. (REGN) | $135.8M | 4.3% | Buy |
| Teva Pharmaceutical Industries Limited (TEVA) | $134.5M | 4.3% | Reduce 26.28% |
| Alphabet Inc. (GOOGL) | $109.5M | 3.5% | Add 7.87% |
| Public Service Enterprise Group Incorporated (PEG) | $109.4M | 3.5% | Add 66.63% |
| The Walt Disney Company (DIS) | $109.1M | 3.5% | Add 34.08% |
| Berkshire Hathaway Inc. (BRK-B) | $105.7M | 3.4% | Add 17.28% |
| Southwest Airlines Co. (LUV) | $104.2M | 3.3% | Reduce 0.67% |
| QUALCOMM Incorporated (QCOM) | $100.7M | 3.2% | Add 3.61% |
| Salesforce, Inc. (CRM) | $100.3M | 3.2% | Buy |
| The AES Corporation (AES) | $98.9M | 3.1% | Add 17.00% |
This table illustrates Sound Shore's measured concentration, with no single holding exceeding 4.3% and the top 10 totaling 35.3%. The mix of buys (REGN, CRM), aggressive adds (PEG up 66.63%, DIS up 34.08%), and trims (TEVA down 26.28%) shows tactical rebalancing toward perceived value. Such positioning mitigates risk while amplifying upside from winners like utilities and biotech.
Investment Lessons from Sound Shore Management
Sound Shore Management's Q4 2025 portfolio demonstrates timeless value principles tailored to modern markets:
- Selective aggression in undervalued sectors: Massive adds like 66.63% to PEG reward deep research into stable growers.
- Long-term holding discipline: 8-quarter average tenure emphasizes patience over trading noise.
- Diversified conviction: 37 positions with 35.3% top-10 weighting balances focus and safety.
- Trim winners, add opportunities: Reducing TEVA by 26.28% while buying REGN shows profit-taking and rotation.
- Quality at any speed: Boosts to BRK-B and GOOGL prioritize moats over pure cheapness.
Looking Ahead: What Comes Next?
Sound Shore's positioning sets up for resilience in uncertain 2026 markets, with utilities like PEG and AES hedging rate volatility and tech adds (GOOGL, QCOM) capturing AI tailwinds. The 18.9% turnover and single-position trim suggest cash availability for deployments in consumer recovery (DIS) or further pharma bets. Inflation moderation could boost BRK-B, while monitoring travel (LUV) for demand rebound. Track via Sound Shore's portfolio page for Q1 updates.
FAQ about Sound Shore Management Portfolio
Q: What were the most significant changes in Sound Shore's Q4 2025 13F filing?
A: Key moves included a new buy in REGN 4.3%, a 66.63% add to PEG 3.5%, 34.08% to DIS 3.5%, and a 26.28% reduction in TEVA 4.3%, alongside new CRM.
Q: Why does Sound Shore maintain a relatively low top-10 concentration?
A: At 35.3%, the top 10 reflects a diversified value strategy across 37 holdings, prioritizing risk control while sizing up high-conviction ideas like utilities and tech without overexposure.
Q: What sectors is Sound Shore overweight in?
A: Healthcare (REGN, TEVA), technology (GOOGL, QCOM), and utilities (PEG, AES) dominate recent activity.
Q: How can I track Sound Shore Management's portfolio and 13F filings?
A: Use ValueSense's superinvestor tracker at https://valuesense.io/superinvestors/sound-shore for real-time updates, historical changes, and visualizations. Note the 45-day 13F reporting lag means positions may have evolved post-filing.
Explore More Investment Opportunities
For investors seeking undervalued companies with high fundamental quality, our analytics team provides curated stock lists:
📌 50 Undervalued Stocks (Best overall value plays for 2026)
📌 50 Undervalued Dividend Stocks (For income-focused investors)
📌 50 Undervalued Growth Stocks (High-growth potential with strong fundamentals)
🔍 Check out these stocks on the Value Sense platform for free!